The contractor’s primary responsibilities may include: Developing a working knowledge of the requirements of M.G.L. c. 6D, the HPC’s enabling statute, including M.G.L. c. 6D § 8A and its implementing regulation, and its relation to M.G.L. c. 118E § 12A. Advising the HPC in its development of methods and frameworks, and in identifying available data and resources, to assess pharmaceutical value. Providing clinical expertise and analytic support to assist the HPC in evaluating the value of certain pharmaceuticals and therapeutic alternatives including advising the HPC in its assessment of information received from manufacturers and other stakeholders, as well as public and confidential data sources. Providing expertise and analytic support to the HPC in health economics, value assessments, and drug pricing, including advising the HPC in its assessment of information received from manufacturers and other stakeholders, as well as public and confidential data sources. Providing subject matter expertise to the HPC on other research as needed on pharmaceutical pricing and policy, including pharmaceutical spending trends, and research on the pharmaceutical financing, distribution and delivery system.